Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-026652

See Remarks gave up 470 shares (to pay taxes)

  • See Remarks acquired 18,757 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Huang Dennis Karl See Remarks 2024-03-01 Grant or award +17,800 82,515 D
Huang Dennis Karl See Remarks 2024-03-01 Grant or award +957 83,472 D
Huang Dennis Karl See Remarks 2024-03-01 Shares withheld for taxes −470 $53.69 $25,234 83,002 D
Derivatives
Huang Dennis Karl See Remarks 2024-03-01 Grant or award · Stock Option (Right to Buy) +31,400 31,400 D
Loading xslF345X05/ownership.xml…